XML 41 R63.htm IDEA: XBRL DOCUMENT v3.20.1
Stockholders' Equity - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 12 Months Ended
Mar. 31, 2020
Jan. 31, 2020
Apr. 30, 2018
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
May 10, 2019
Jan. 31, 2017
Jan. 25, 2016
Subsidiary, Sale of Stock [Line Items]                        
Common stock, shares authorized             600,000,000 600,000,000   600,000,000    
Preferred stock, shares authorized             2,000,000 2,000,000   2,000,000    
Common stock, shares outstanding             32,352,416 19,222,410        
Sales per share price range                       $ 111.20
Proceeds from shares sold             $ 97,890 $ 100,060 $ 63,425      
Common Stock [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Shares sold             12,980,177 2,941,438 2,544,495      
Proceeds from shares sold             $ 130 $ 29 $ 25      
December 2018 Sales Agreement [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Shares sold             10,500,000          
Proceeds from shares sold             $ 59,500          
Shelf Registration Statement, Authorized Common Stock Issuance, Value             $ 100,000          
December 2018 Sales Agreement [Member] | Subsequent Event [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Shares sold       7,200,000                
Proceeds from shares sold       $ 38,500                
Shelf Registration Statement, Maximum Authorized Common Stock Issuance, Value $ 500     500                
Public Offering [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Sales per share price range     $ 33.00                  
Shares sold     1,700,000                  
Common stock issued upon exercise in full over-allotment granted     200,000                  
Proceeds from shares sold     $ 54,000                  
Payments of Stock Issuance Costs     $ 3,600                  
December 2017 Sales Agreement [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Shares sold         2,500,000     900,000        
Proceeds from shares sold         $ 37,900     $ 35,900        
Shelf Registration Statement, Authorized Common Stock Issuance, Value                 $ 75,000      
January 2017 Sales Agreement [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Shares sold           300,000     2,500,000      
Proceeds from shares sold           $ 10,300     $ 63,400      
Shelf Registration Statement, Authorized Common Stock Issuance, Value                     $ 75,000  
January 2020 Sales Agreement [Member] | Subsequent Event [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Proceeds from shares sold   $ 100,000                    
January 2020 Sales Agreement [Member] | Subsequent Event [Member] | Common Stock [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Shares sold   10,500,000                    
Proceeds from shares sold   $ 98,700                    
March 2020 Sales Agreement [Member] | Subsequent Event [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Proceeds from shares sold $ 150,000                      
March 2020 Sales Agreement [Member] | Subsequent Event [Member] | Common Stock [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Shares sold 1,500,000                      
Proceeds from shares sold $ 18,600                      
Stock Issued During Period, Value, Other $ 131,100     $ 131,100                
Maximum [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Common stock, shares outstanding                   469,453,883    
Minimum [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Common stock, shares outstanding                   23,472,574